Skip to the content

CurePharma Global

  • UK
Contact us
logo mainlogo darklogo light
Search
logo main
logo main
HomeCurepharmaCurepharma has been granted WDA(H) licence by MHRA
Curepharma

Curepharma has been granted WDA(H) licence by MHRA

CurePharma
6 May 2016

See link 

 

Share share
  • .face-icon{fill:#fff;}
  • .tw-icon{fill:#fff;}
  • .ln-icon{fill:#fff;}
  • .pn-icon{fill:#fff;}
Next post
CurePharma Feature in chamber international news release

Leave a Reply

Your email address will not be published. Required fields are marked *

Related articles

CurePharma
Curepharma
ArabHealth Appointment Scheduling form
CurePharma
27 November 2023
Curepharma
CurePharma have been shortlisted as a finalist for the Powerhouse export awards
CurePharma
8 February 2017
Curepharma
CurePharma COVID-19 Personal Protective Equipment (PPE) Catalogue
CurePharma
10 April 2020
CurePharma

principal scientist

Exploring the World of Dosage Forms: How CurePharma Delivers Comprehensive Manufacturing Solutions (Part 2)

CurePharma
14 January 2025

CurePharma Exhibits at Africa Women’s Health Event: Championing Positive Change and Global Healthcare Accessibility

CurePharma
16 September 2024
Categories
Curepharma Innovation Media R&D Wholesale
w
We believe in innovation
View more

Subscribe for updates

    Company

    • Contact Us
    • Worldwide-Directory
    • FAQ Page
    • CurePharma at a glance

    Innovative

    • Manufacturing
    • Product development
    • Formulation developments
    • CTD-Dossiers

    Products

    • CurePharma Medicines Portfolio
    • CurePharma Consumer Portfolio
    • Medicine Distribution Program
    • Generic and Branded Medicines Supply

    United Kingdom

    • Unit 174, Avenue B, Thorpe Arch Estate, Wetherby LS23 7BJ
    • 0044 1937 339995

    © 2016 CurePharma, All Rights Reserved

    Back to top Drag
    w